Fig. 2
From: Ruxolitinib in refractory acute and chronic graft-versus-host disease: a multicenter survey study
a Overall survival among patients with chronic GVHD. b Overall survival in responders vs non-responder chronic GVHD patients
Fig. 2 | Bone Marrow Transplantation
